Erlolieva 150 Tablet 30's Substitute
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹891.79
(₹80.26 per unit)
RXZydus Cadila
₹3431
(₹93.78 per unit)
RX₹6400
(₹174.93 per unit)
RX₹7200
(₹196.8 per unit)
RX₹7200
(₹196.8 per unit)
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹2340
(₹210.6 per unit)
RXMedicamen Biotech Ltd
₹6660
(₹222.0 per unit)
RXShilpa Medicare Ltd
₹2848.93
(₹233.61 per unit)
RXNatco Pharma Ltd
₹8768.5
(₹239.67 per unit)
RXKhandelwal Laboratories Pvt Ltd
₹8870.4
(₹242.46 per unit)
RX₹12000
(₹328.0 per unit)
RXSamarth Life Sciences Pvt Ltd
₹7000
(₹574.0 per unit)
RXFresenius Kabi India Pvt Ltd
₹25000
(₹683.33 per unit)
RX₹9999
(₹819.92 per unit)
RXRPG Life Sciences Ltd
₹11159.8
(₹915.1 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Erlolieva 150 Tablet 30's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - ERLOTINIB-150MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Erlolieva 150 Tablet 30's is used in the treatment of cancer. The detailed uses of Erlolieva 150 Tablet 30's are as follows:
Erlolieva 150 Tablet 30's is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Erlolieva 150 Tablet 30's travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Erlolieva 150 Tablet 30's contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Erlolieva 150 Tablet 30's targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Erlolieva 150 Tablet 30's stops the production, spread, and growth of cancerous cells in the body.
The substitutes of Erlolieva 150 Tablet 30's contain the same active salt(s) - ERLOTINIB-150MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Erlolieva 150 Tablet 30's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Erlolieva 150 Tablet 30's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Erlolieva 150 Tablet 30's meet the same safety and efficacy standards as Erlolieva 150 Tablet 30's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Erlolieva 150 Tablet 30's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Erlolieva 150 Tablet 30's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Erlolieva 150 Tablet 30's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Erlolieva 150 Tablet 30's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Erlolieva 150 Tablet 30's to its substitute. Always consult your doctor before switching.
Erlolieva 150 Tablet 30's is used to treat lung and pancreatic cancer.
Erlolieva 150 Tablet 30's contains Erlotinib, an anti-cancer medication that works by preventing the activity of a protein called epidermal growth factor receptor (EGFR) and hence induces cell death (apoptosis). As a result, the growth and spread of cancer cells in stopped or slowed down.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.
Erlolieva 150 Tablet 30's is safe to be taken by a diabetic person. However, take Erlolieva 150 Tablet 30's only after asking with a doctor as they may adjust the dosing according to the patient's condition.
In elderly patients, the risk of side effects is more if you are taking Erlolieva 150 Tablet 30's. For the patients who are elderly, dose adjustment might be required or your doctor might prescribe any other medication safe for the elderly.
Erlolieva 150 Tablet 30's can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details.
No, It is advised to maintain a gap between both the medicines, as use of antacids along with Erlolieva 150 Tablet 30's may affect the way the Erlolieva 150 Tablet 30's works. Consult your doctor for further information.
Erlolieva 150 Tablet 30's should be used with caution in patients using anticoagulants. Erlolieva 150 Tablet 30's may increase your tendency to bleed. Talk to your doctor, he will need to regularly monitor you with some blood tests.
Erlolieva 150 Tablet 30's is not recommended for children under 18 years of age, as its safety and efficacy were not established.
No, you should not take Erlolieva 150 Tablet 30's if you are pregnant or planning to become pregnant as it may cause harm to an unborn baby. Consult the doctor if you have any concerns.
No, do not take Erlolieva 150 Tablet 30's with food. It can be taken orally on an empty stomach, at least 1 hour before or 2 hours after meals.
Erlolieva 150 Tablet 30's is a targeted therapy used to treat specific types of non-small cell lung cancer that spread to nearby tissues or any other parts of the body in patients who have previously undergone at least one chemotherapy treatment without improvement.
Erlolieva 150 Tablet 30's should be taken for as long as your doctor has prescribed it, depending on your medical condition. Please consult the doctor if you have any concerns regarding the duration of treatment.
Yes, Smoking may interfere with Erlolieva 150 Tablet 30's. It lowers the levels of Erlolieva 150 Tablet 30's in the blood, potentially reducing its effectiveness in treating the cancer. Avoid smoking while on treatment with Erlolieva 150 Tablet 30's to treat your condition effectively.
Inform the doctor if you notice a rash while taking Erlolieva 150 Tablet 30's as it could be a symptom of an allergic reaction.
Erlolieva 150 Tablet 30's may harm the foetus. Therefore, it is not recommended to become pregnant during treatment with Erlolieva 150 Tablet 30's. Use effective birth control while taking Erlolieva 150 Tablet 30's and for at least one month after your final dose. Talk to the doctor if you plan to become pregnant; the doctor will provide guidance on the same.
Erlolieva 150 Tablet 30's may cause sparse eyelashes (thinning of eyelashes), blepharitis (inflammation of eyelids), and diffuse conjunctival congestion (redness of the eye). Consult the doctor if you notice any eye problems.
Call your doctor if you experience severe diarrhoea, nausea, vomiting, loss of appetite, worsening shortness of breath or cough, new or worsening rash, blistering or peeling of the skin, eye irritation or any changes in smoking habits during treatment with Erlolieva 150 Tablet 30's.